Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia

References

• Nienhuis AW, Nathan DG. Pathophysiology and clinical manifestations of the β-thalassemias. Cold Spring Harb Perspect Med. 2012;2(12):a011726. DOI:10.1101/cshperspect.a011726.
   PubMed Web of Science ®Google Scholar
• Xia S, Zhang W, Huang L, et al. Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials. PLoS One. 2013;8:e82662.
   PubMed Web of Science ®Google Scholar
• Cavazzana M, Antoniani C, Miccio A. Gene therapy for β-hemoglobinopathies. Mol Ther. 2017;25:1142–1154.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, et al. Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536–2559.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Eleftheriou A, Malaventura C, et al. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev. 2004;2(Suppl 2):249–255.
   PubMedGoogle Scholar
• De Sanctis V, Soliman AT, Elsedfy H, et al. Late-onset male hypogonadism and fertility potential in thalassemia major patients: two emerging issues. Mediterr J Hematol Infect Dis. 2015 Jul 10;7(1):e2015047.
   PubMedGoogle Scholar
• Papadimas J, Goulis DG, Mandala E, et al. β-thalassemia and gonadal axis: a cross-sectional, clinical study in a Greek population. Hormones (Athens). 2002;1:179–187.
   PubMedGoogle Scholar
• Srisukh S, Ongphiphadhanakul B, Bunnag P. Hypogonadism in thalassemia major patients. J Clin Transl Endocrinol. 2016;5:42–45.
   PubMedGoogle Scholar
• Al-Akhras A, Badr M, El-Safy U, et al. Impact of genotype on endocrinal complications in β-thalassemia patients. Biomed Rep. 2016;4:728–736.
   PubMed Web of Science ®Google Scholar
• Marshall WA, Tanner JM. Variations in the pattern of pubertalchanges in boys. Arch Dis Child. 1970;45:13–23.
   PubMed Web of Science ®Google Scholar
• Zappulla F, Balsamo A, Tassinari D, et al. [Relations between hypothalamo-hypophyseal-gonadal function and hemoglobin level in the polytransfused thalassemic child]. Minerva Pediatr. 1981;33:317–322.
   PubMed Web of Science ®Google Scholar
• Soliman AT, Abushahin A, Abohezeima K, et al. Age related IGF-I changes and IGF-I generation in thalassemia major. Pediatr Endocrinol. 2011;8(Suppl 2):278–283.
   Google Scholar
• Yassin MA, Soliman AT, De Sanctis V. Anemia (IDA): effects on pituitary gonadal axis and sperm parameters. Blood. 2013;122:967.
   Web of Science ®Google Scholar
• Soliman A, Yasin M, El-Awwa A, et al. Acute effects of blood transfusion on pituitary gonadal axis and sperm parameters in adolescents and young men with thalassemia major: a pilot study. Fertil Steril. 2012;98:638–643.
   PubMed Web of Science ®Google Scholar
• Soliman AT, Yasin M, El-Awwa A, et al. Does blood transfusion affect pituitary gonadal axis and sperm parameters in young males with sickle cell disease? Indian J Endocrinol Metab. 2013;17:962–968.
   PubMedGoogle Scholar
• Soliman A, Yassin M, De Sanctis V. Intravenous iron replacement therapy in eugonadal males with iron-deficiency anemia: effects on pituitary gonadal axis and sperm parameters; a pilot study. Indian J Endocrinol Metab. 2014;18:310–316.
   PubMedGoogle Scholar
• Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21;5: 11. DOI:10.1186/1750-1172-5-11.
   PubMed Web of Science ®Google Scholar
• Sampaio AF, Silva M, Dornas WC, et al. Iron toxicity mediated by oxidative stress enhances tissue damage in an animal model of diabetes. Biometals. 2014;27:349–361.
   PubMed Web of Science ®Google Scholar
• Boudrahem-Addour N, Izem-Meziane M, Bouguerra K, et al. Oxidative status and plasma lipid profile in β-thalassemia patients. Hemoglobin. 2015;39:36–41.
   PubMed Web of Science ®Google Scholar
• Cianciulli P, Del Poeta G. Reperti istopatologici gonadici ed ipofisari nell’anemia di Cooley. In: De Sanctis V, editor La maturazione sessuale nella β- Talassemia major. Ferrara: Tipografia Artigiana F.lli Dasi; 1986. p. 107–116.
   Google Scholar
• Oudit GY, Trivieri MG, Khaper N, et al. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med (Berl). 2006;84:349–364.
   PubMed Web of Science ®Google Scholar
• Hezareh M, Schlegel W, Rawlings SR. Stimulation of Ca2+influx in alpha T3-1 gonadotrophs via the cAMP/PKA signaling system. Am J Physiol. 1997;273:E850–E858.
   PubMedGoogle Scholar
• González-Duarte D, Madrazo-Atutxa A, Soto-Moreno A, et al. Measurement of oxidative stress and endothelial dysfunction in patients with hypopituitarism and severe deficiency adult growth hormone deficiency. Pituitary. 2012;15:589–597.
   PubMed Web of Science ®Google Scholar
• Claster S, Wood JC, Noetzli L, et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol. 2009;84:344–348.
   PubMed Web of Science ®Google Scholar
• Kiess W, Blum WF, Aubert ML. Leptin, puberty and reproductive function: lessons from animal studies and observations in humans. Eur J Endocrinol. 1998;138:26–29.
   PubMed Web of Science ®Google Scholar
• Smith GD, Jackson LM, Foster DL. Leptin regulation of reproductive function and fertility. Theriogenology. 2002;57:73–86.
   PubMed Web of Science ®Google Scholar
• Adam CL, Archer ZA, Miller DW. Leptin actions on the reproductive neuroendocrine axis in sheep. Reprod. 2003;Suppl 61:283–297.
   Google Scholar
• Moshtaghi-Kashanian GR, Razavi F. Ghrelin and leptin levels in relation to puberty and reproductive function in patients with beta-thalassemia. Hormones (Athens). 2009;8:207–213.
   PubMedGoogle Scholar
• Al-Naama LM, Hassan MK, Abdul Karim MM. Evaluation of serum leptin levels and growth in patients with β-thalassaemia major. Anemia. 2016:8454286 Epub 2016 Mar 21. 10.1155/2016/8454286
   PubMed Web of Science ®Google Scholar
• Kharb S, Garg MK, Puri P, et al. Assessment of thyroid and gonadal function in liver diseases. Indian J Endocr Metab. 2015;19:89–94.
   PubMedGoogle Scholar
• Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol. 2005;152:501–513.
   PubMed Web of Science ®Google Scholar
• Kadjbaf D, Keshvari M, Alavian SM, et al. The prevalence of hepatitis C virus core amino acid 70 substitution and genotypes of polymorphisms near the IFNL3 gene in Iranian patients with chronic hepatitis C. Hepat Mon. 2016 May 3;16(6):e37011. 37011. DOI:10.5812/hepatmon
   PubMed Web of Science ®Google Scholar
• Dore GJ, Freeman AJ, Law M, et al. Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol. 2002;17:423–430.
   PubMed Web of Science ®Google Scholar
• Singer F, Zumoff B. Subnormal serum testosterone levels in male internal medicine residents. Steroids. 1992;57:86–89.
   PubMed Web of Science ®Google Scholar
• Messina G, Colombo E, Cassinerio E, et al. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med. 2008;3:339–343.
   PubMed Web of Science ®Google Scholar
• Gamberini MR, De Sanctis V, Hypogonadism GG. Diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008;6(Suppl 1):158–169.
   PubMedGoogle Scholar
• Belhoul KM, Bakir ML, Saned MS, et al. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol. 2012;91:1107–1114.
   PubMed Web of Science ®Google Scholar
• Shalitin S, Carmi D, Weintrob N, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005;74:93–100.
   PubMed Web of Science ®Google Scholar
• Chirico V, Rigoli L, Lacquaniti A, et al. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Eur J Haematol. 2015;94:404–412.
   PubMed Web of Science ®Google Scholar
• Khera M, Broderick GA, Carson CC 3rd, et al. Adult-onset hypogonadism. Mayo Clin Proc. 2016;91:908–926.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Elsedfy H, Soliman AT, et al. Acquired hypogonadotropic hypogonadism (AHH) in thalassaemia major patients: an underdiagnosed condition? Mediterr J Hematol Infect Dis. 2016;8(1):e2016001.
   PubMedGoogle Scholar
• Albu A, Barbu CG, Antonie L, et al. Risk factors associated with hypogonadism in ß thalassemia major patients: predictors for a frequent complication of a rare disease. Postgr Med. 2014;126:121–127.
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Katz M. Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clin Endocrinol (Oxf). 2000;53:33–42.
   PubMed Web of Science ®Google Scholar
• Soliman AT, elZalabany MM, Ragab M, et al. Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty. J Trop Pediatr. 2000;46:79–85.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Elsedfy H, Soliman AT, et al. Clinical and biochemical data of adult thalassemia major patients (TM) with multiple endocrine complications (MEC) versus TM patients with normal endocrine functions: a long-term retrospective study (40 years) in a tertiary care center in Italy. Mediterr J Hematol Infect Dis. 2016 Apr 12;8(1):e2016022. DOI:10.4084/MJHID.2016.022.
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, Panigrahy A, Mittelman SD, et al. Pituitary iron and volume predict hypogonadism in transfusional iron overload. Am J Hematol. 2012;87:167–171.
   PubMed Web of Science ®Google Scholar
• Hekmatnia A, Radmard AR, Rahmani AA, et al. Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta-thalassemic patients. Acta Radiol. 2010;51:71–77.
   PubMed Web of Science ®Google Scholar
• Argyropoulou MI, Kiortsis DN, Metafratzi Z, et al. Pituitary gland height evaluated by MR in patients with beta-thalassemia major: a marker of pituitary gland function. Neuroradiology. 2001;43:1056–1058.
   PubMed Web of Science ®Google Scholar
• Berkovitch M, Bistritzer T, Milone SD, et al. Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRIevaluation and correlation with gonadal function. J Pediatr Endocrinol Metab. 2000;13:179–184.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: World Health Organization; 2010. p. 7–37.
   Google Scholar
• Skordis N, Michaelidou M, Savva SC, et al. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol. 2006;77:150–156.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Soliman AT, Candini G, et al. The recommendation of the international network of clinicians for endocrinopathies in thalassemia and adolescent medicine for the assessment of growth hormone secretion in thalassemia. Indian J Endocrinol Metab. 2015;19:306–307.
   PubMedGoogle Scholar
• Kyriakou A, Savva SC, Savvides I, et al. Gender differences in the prevalence and severity of bone disease in thalassaemia. Pediatr Endocrinol Rev. 2008;6(Suppl 1):116–122.
   PubMedGoogle Scholar
• De Sanctis V, Roos M, Gasser T, et al. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006;19:471–480.
   PubMed Web of Science ®Google Scholar
• Casale M, Citarella S, Filosa A, et al. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. Am J Hematol. 2014;89:1102–1106.
   PubMed Web of Science ®Google Scholar
• Farmaki K, Tzoumari I, Pappa C, et al. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. Br J Haematol. 2010;148:466–475.
   PubMed Web of Science ®Google Scholar
• Poggi M, Sorrentino F, Pugliese P, et al. Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years. Ann Hematol. 2016;95:757–763.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Borsari G, Brachi S, et al. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine. Georgian Med News. 2008;156:74–77.
   Google Scholar
• Kajanachumpol S, Tatu T, Sasanakul W. Zinc and copper status of thalassemia children. Southeast Asian J Trop Med Public Health. 1997;28:877–880.
   PubMedGoogle Scholar
• Singer ST, Killilea D, Suh JH, et al. Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis. Am J Hematol. 2015;90:E190–E1922.
   PubMed Web of Science ®Google Scholar
• Carpino A, De Sanctis V, Siciliano L, et al. Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: evidence of an impaired prostatic function. Exp Clin Endocrinol Diabetes. 1997;105:169–174.
   PubMed Web of Science ®Google Scholar
• Ebisch IM, Thomas CM, Peters WH, et al. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13:163–174.
   PubMed Web of Science ®Google Scholar
• Schmid TE, Eskenazi B, Marchetti F, et al. Micronutrients intake is associated with improved sperm DNA quality in older men. Fertil Steril. 2012;98:1130–1137.
   PubMed Web of Science ®Google Scholar
• Hackett G. An update on the role of testosterone replacement therapy in the management of hypogonadism. Ther Adv Urol. 2016;8:147–160.
   PubMed Web of Science ®Google Scholar
• Soliman AT, Nasr I, Thabet A, et al. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major. Metabolism. 2005;54:15–23.
   PubMed Web of Science ®Google Scholar
• Cisternino M, Manzoni SM, Coslovich E, et al. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):885–890.
   PubMedGoogle Scholar
• Petak SM, Nankin HR, Spark RF, et al.; American Association of Clinical Endocrinologists. American Association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients–2002 update. Endocr Pract. 2002;8:440–456.
   PubMedGoogle Scholar
• Aversa A, Morgentaler A. The practical management of testosterone deficiency in men. Nat Rev Urol. 2015;12:641–650.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Strasser S, McDonald JA, et al. Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clin Endocrinol (Oxf). 1995;43:331–337.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Foroughi AA, Haghpanah S, et al. Incidence of testicular microlithiasis in patients with β-thalassemia major. Ann Hematol. 2015;94:1785–1789.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Vullo C, Katz M, et al. Induction of spermatogenesis in thalassaemia. Fertil Steril. 1988;50:969–975.
   PubMed Web of Science ®Google Scholar
• Bajoria R, Chatterjee R. Hypogonadotrophic hypogonadism and diminished gonadal reserve accounts for dysfunctional gametogenesis in thalassaemia patients with iron overload presenting with infertility. Hemoglobin. 2011;35:636–642.
   PubMed Web of Science ®Google Scholar
• Liu PY, Baker HW, Jayadev V, et al. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801–808.
   PubMed Web of Science ®Google Scholar
• Zorn B, Pfeifer M, Virant-Klun I, et al. Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism. Int J Androl. 2005;28:202–207.
   PubMedGoogle Scholar
• Bakircioglu ME, Erden HF, Ciray HN, et al. Gonadotrophin therapy in combination with ICSI in men with hypogonadotrophic hypogonadism. Reprod Biomed Online. 2007;15:156–160.
   PubMed Web of Science ®Google Scholar
• Perera D, Pizzey A, Campbell A, et al. Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. Hum Reprod. 2002;17:1820–1825.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Perera D, Katz M, et al. Spermatozoal DNA damage in patients with B thalassaemia syndromes. Pediatr Endocrinol Rev. 2008;6(Suppl 1):185–189.
   PubMedGoogle Scholar
• Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547–764.
   PubMed Web of Science ®Google Scholar
• Grinspon R, Rey RA. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker. Arq Bras Endocrinol Metab. 2011;55:512–519.
   PubMedGoogle Scholar